17 May 2023 Blog Defensive Lines - a report by our cyber response team Cyber threats are here to stay. Mills & Reeve's new report, Defensive Lines, provides a useful benchmark to take stock of an organisation's own preparation and response practices and procedures. Share this article Bookmark this page 1 min read
9 May 2023 Insight Strengthening the UK clinical research environment A recent ABPI report highlighted a decline in UK clinical trials. Improving the UK ecosystem for clinical research will involve a range of measures, and we look forward to publication of the O’Shaughnessy review. This sits alongside an ongoing substantial upgrade to UK clinical trials legislation and guidance, that forms the focus of this article. Bookmark this page 6 min read
9 May 2023 Insight Initial experiences with the Clinical Trials Regulation and CTIS in Germany The EU Clinical Trials Regulation (EU) 536/2014 (the CTR) became applicable on 31 January 2022. We asked our best friend firm in Germany, Graf von Westphalen, to give us an insight into how the CTR and the related Clinical Trials Information System (CTIS) are bedding in. Bookmark this page 4 min read
2 May 2023 Insight University spin-outs, students as consumers and fair terms – what can we learn from the Oxford Nanoimaging case? Universities and spin-out companies should be reviewing their general position in relation to intellectual property ownership in light of the court’s decision in the recent case of Oxford University Innovations v Oxford Nanoimaging 2022. Bookmark this page 6 min read